ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 86 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,000 | +150.0% | 500 | +426.3% | 0.00% | – |
| Q3 2018 | $2,000 | -98.4% | 95 | -98.8% | 0.00% | -100.0% |
| Q2 2018 | $128,000 | +481.8% | 8,054 | +311.3% | 0.01% | +133.3% |
| Q4 2017 | $22,000 | -75.0% | 1,958 | -53.7% | 0.00% | -70.0% |
| Q4 2016 | $88,000 | – | 4,227 | +46866.7% | 0.01% | – |
| Q3 2016 | $0 | -100.0% | 9 | -99.6% | 0.00% | -100.0% |
| Q1 2016 | $60,000 | +500.0% | 2,434 | +680.1% | 0.01% | +350.0% |
| Q4 2015 | $10,000 | +66.7% | 312 | +76.3% | 0.00% | +100.0% |
| Q3 2015 | $6,000 | -88.2% | 177 | -81.8% | 0.00% | -80.0% |
| Q2 2015 | $51,000 | -10.5% | 971 | -50.6% | 0.01% | -28.6% |
| Q1 2015 | $57,000 | +171.4% | 1,965 | +168.1% | 0.01% | +250.0% |
| Q4 2014 | $21,000 | -82.8% | 733 | -87.9% | 0.00% | -87.5% |
| Q2 2014 | $122,000 | – | 6,058 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |